anti-Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) Antibodies

The uptake of nucleosides by transporters, such as SLC29A2, is essential for nucleotide synthesis by salvage pathways in cells that lack de novo biosynthetic pathways. Additionally we are shipping SLC29A2 Proteins (4) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
SLC29A2 3177 Q14542
SLC29A2 13340 Q61672
SLC29A2 65194 O54699
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-SLC29A2 Antibodies at antibodies-online.com

Showing 10 out of 44 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Cow Rabbit Un-conjugated WB Host: Rabbit Target Name: SLC29A2 Sample Tissue: Human Ovary Tumor Antibody Dilution: 1.0ug/ml Host: Rabbit Target Name: SLC29A2 Sample Type: Human Fetal Liver Antibody Dilution: 1.0ug/ml 100 μL 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated IHC, WB Human kidney 100 μL 2 to 3 Days
$249.00
Details
Cow Rabbit Un-conjugated WB Western blot analysis of ENT2 expression in HEK293T (A), Raw264.7 (B) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Details
Human Rabbit Un-conjugated IHC, IHC (p), WB 100 μL 11 to 14 Days
$507.83
Details
Horse Rabbit Un-conjugated WB 100 μL 11 to 14 Days
$551.83
Details
Human Rabbit Un-conjugated WB Mouse heart lysates probed with Rabbit Anti-ENT2 Polyclonal Antibody, Unconjugated (ABIN2559658) at 1:300 in 4˚C. Followed by conjugation to secondary antibody at 1:5000 for 90min at 37˚C. Formalin-fixed and paraffin embedded human laryngeal tissue labeled with Rabbit Anti-ENT2 Polyclonal Antibody, Unconjugated (ABIN2559658) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL 3 to 7 Days
$317.90
Details
Human Rabbit Un-conjugated ELISA, IHC, IHC (p), WB Human Skeletal Muscle: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg 11 to 14 Days
$616.00
Details
Human Mouse Un-conjugated IF, WB Western Blot analysis of SLC29A2 expression in transfected 293T cell line by SLC29A2 MaxPab polyclonal antibody.Lane 1: SLC29A2 transfected lysate(50.16 KDa).Lane 2: Non-transfected lysate. Immunofluorescence of purified MaxPab antibody to SLC29A2 on HeLa cell. [antibody concentration 10 ug/ml] 50 μL 11 to 12 Days
$364.00
Details
Human Rabbit Un-conjugated IHC, ELISA, WB 100 μL 2 to 3 Days
$446.88
Details
Human Rabbit Un-conjugated ELISA, IF, IHC (p), WB   0.1 mg 2 to 3 Days
$360.00
Details

Top referenced anti-SLC29A2 Antibodies

  1. Human Polyclonal SLC29A2 Primary Antibody for IHC, WB - ABIN2781571 : Owen, Lagpacan, Taylor, De La Cruz, Huang, Kawamoto, Johns, Stryke, Ferrin, Giacomini: Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. in Drug metabolism and disposition: the biological fate of chemicals 2005 (PubMed)
    Show all 2 Pubmed References

  2. Cow (Bovine) Polyclonal SLC29A2 Primary Antibody for WB - ABIN2781572 : Bone, Hammond: Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter. in American journal of physiology. Heart and circulatory physiology 2007 (PubMed)

More Antibodies against SLC29A2 Interaction Partners

Human Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) interaction partners

  1. two novel functional splice variants of equilibrative nucleoside transporter 2 (ENT2), which are present at the nuclear envelope, were identified.

  2. Results showed that both SLC29A1 and SLC29A2 were expressed at lower levels in colon cancer cell lines originating from metastatic sites than from primary sites.

  3. Direct evidence for apical localization of ENT1 and integral expression of ENT2 in intestinal epithelial cells.

  4. these findings reveal the transcriptional repression of ENT1,2 as an innate protective response during acute pulmonary inflammation.

  5. Data suggest that SLC29A2 is localized to apical membrane of adult Sertoli cells. In contrast, SLC29A1 is located on basolateral membrane of Sertoli cells; SLC29A1 is primarily responsible for basolateral nucleoside uptake into Sertoli cells.

  6. Data show that ENT1, ENT2, ENT4 and CNT3 protein was detected on ovarian carcinoma cells in all effusions, with expression observed in 1-95% of tumor cells.

  7. Studies show that ABCC4 and SLC29A2 expression were predictive of achieving CR, and the high expression of GSTP1 suggests that this may be a therapeutic target for relapsed AML.

  8. role in functional and molecular characterization of nucleobase transport

  9. hENT1 and hENT2 on the basolateral membrane function with concentrative nucleoside transporters on the apical membrane to mediate active reabsorption of nucleosides within the kidney.

  10. an analysis of function by site-directed glycosylation mutagenesis

  11. Equilibrative nucleoside transporters (hENT1, hENT2) together with adenosine kinase and 5'-nucleotidase play a crucial role in the regulation of CFTR through an adenosine-dependent pathway in human airway epithelia.

  12. Only a few endometrial carcinomas (15%) were found to be negative for hCNT1, but they all retained hENT1 and hENT2 expression.

  13. residue 33 resides in an extracellular domain as predicted by the current hENT2 topology model and suggested that it is a functionally important component of both the permeant and dipyridamole binding sites.

  14. the corresponding residues in TMs 1 and 11 of hENT1, hENT2, and CeENT1 are important for dipyridamole interactions and nucleoside transport.

  15. The low overall genetic diversity in SLC29A2 makes it unlikely that variation in the coding region contributes significantly to clinically observed differences in drug response.

  16. Data show that insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.

  17. Human cardiac microvascular endothelial cells rely on ENT1 for nucleoside transport with little contribution from ENT2.

  18. These data suggest that selected genes of the SLC28 and SLC29 families are not only targets of HIV-1 infection, but might also contribute to the development of adipose tissue alterations leading to lipodystrophy.

  19. Report expression and hepatobiliary transport characteristics of ENT2 in sandwich-cultured human hepatocytes.

  20. hPMEC from pre-eclampsia exhibit increased total transport (hENT1+hENT2), and maximal velocity (Vmax) for hENT2- (2-fold), but reduced Vmax for hENT1-mediated adenosine transport

Mouse (Murine) Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) interaction partners

  1. Data suggest that crosstalk pathway between ENT2 and alveolar epithelial Adora2b in lung protection during acute lung injury (ALI) opens possibilities for combined therapies targeted to this protein set.

  2. these findings reveal the transcriptional repression of ENT1,2 as an innate protective response during acute pulmonary inflammation.

  3. Inosine and ENT-2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.

  4. HIF-1alpha-dependent repression of ENT2 increases mucosal adenosine signaling and attenuates hypoxia-associated inflammation of the intestine.

Cow (Bovine) Solute Carrier Family 29 (Nucleoside Transporters), Member 2 (SLC29A2) interaction partners

  1. Ruminal infusion of starch hydrolysate increased duodenal and ileal expression ENT2 mRNA. Abomasal infusion increased ileal and jejunal ENT2 mRNA expression.

SLC29A2 Antigen Profile

Protein Summary

The uptake of nucleosides by transporters, such as SLC29A2, is essential for nucleotide synthesis by salvage pathways in cells that lack de novo biosynthetic pathways. Nucleoside transport also plays a key role in the regulation of many physiologic processes through its effect on adenosine concentration at the cell surface (Griffiths et al., 1997

Gene names and symbols associated with SLC29A2

  • solute carrier family 29 member 2 (SLC29A2) antibody
  • solute carrier family 29 (nucleoside transporters), member 2 (Slc29a2) antibody
  • solute carrier family 29 member 2 (Slc29a2) antibody
  • solute carrier family 29 (equilibrative nucleoside transporter), member 2 L homeolog (slc29a2.L) antibody
  • solute carrier family 29 (equilibrative nucleoside transporter), member 2 (slc29a2) antibody
  • der12 antibody
  • DKFZp468L038 antibody
  • ent2 antibody
  • hnp36 antibody
  • MGC82995 antibody
  • zgc:110527 antibody

Protein level used designations for SLC29A2

36 kDa nucleolar protein HNP36 , delayed-early response protein 12 , equilibrative NBMPR-insensitive nucleoside transporter , equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter , equilibrative nucleoside transporter 2 , hydrophobic nucleolar protein, 36 kDa , hydrophobic nucleolar protein, 36kD , nucleoside transporter, ei-type , solute carrier family 29 (nucleoside transporters), member 2 , solute carrier family 29 member 2 , 36 kDa hydrophobic nucleolar protein , delayed early response gene 12 , solute carrier family 29, member 2 , NBMPR-insensitive nucleoside transporter ei

GENE ID SPECIES
3177 Homo sapiens
13340 Mus musculus
65194 Rattus norvegicus
444417 Xenopus laevis
451345 Pan troglodytes
531564 Bos taurus
548864 Xenopus (Silurana) tropicalis
611913 Canis lupus familiaris
100009420 Oryctolagus cuniculus
100294577 Pongo abelii
100052412 Equus caballus
100715030 Cavia porcellus
100518596 Sus scrofa
503537 Danio rerio
Selected quality suppliers for anti-SLC29A2 (SLC29A2) Antibodies
Did you look for something else?